Cargando…

The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease

Detalles Bibliográficos
Autores principales: Yilmaz, Yusuf, Kaya, Eda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209980/
https://www.ncbi.nlm.nih.gov/pubmed/37250928
http://dx.doi.org/10.14744/hf.2022.2022.0044
_version_ 1785046980013064192
author Yilmaz, Yusuf
Kaya, Eda
author_facet Yilmaz, Yusuf
Kaya, Eda
author_sort Yilmaz, Yusuf
collection PubMed
description
format Online
Article
Text
id pubmed-10209980
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-102099802023-05-26 The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease Yilmaz, Yusuf Kaya, Eda Hepatol Forum Editorial Kare Publishing 2023-05-18 /pmc/articles/PMC10209980/ /pubmed/37250928 http://dx.doi.org/10.14744/hf.2022.2022.0044 Text en © Copyright 2023 by Hepatology Forum https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Editorial
Yilmaz, Yusuf
Kaya, Eda
The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title_full The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title_fullStr The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title_full_unstemmed The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title_short The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease
title_sort role of fibroscan in the era of metabolic (dysfunction)-associated fatty liver disease
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209980/
https://www.ncbi.nlm.nih.gov/pubmed/37250928
http://dx.doi.org/10.14744/hf.2022.2022.0044
work_keys_str_mv AT yilmazyusuf theroleoffibroscanintheeraofmetabolicdysfunctionassociatedfattyliverdisease
AT kayaeda theroleoffibroscanintheeraofmetabolicdysfunctionassociatedfattyliverdisease
AT yilmazyusuf roleoffibroscanintheeraofmetabolicdysfunctionassociatedfattyliverdisease
AT kayaeda roleoffibroscanintheeraofmetabolicdysfunctionassociatedfattyliverdisease